Marketdash
Back to News

Wall Street Sees Dick's Sporting Goods Jumping 17% Plus 9 Other Friday Forecast Moves

MarketDash Editorial Team
10 days ago
Analysts made some notable calls on Friday, adjusting price targets across retail, pharma, and industrial sectors. Dick's Sporting Goods caught attention with a target suggesting significant upside, while targets shifted dramatically for companies ranging from discount retailers to Chinese EV makers.

Wall Street analysts shuffled their price targets across a diverse group of stocks Friday, making moves that ranged from modest tweaks to dramatic reassessments. The headline grabber? Dick's Sporting Goods Inc (DKS) maintained its bullish outlook despite a slight trim, while several other retail names caught fresh attention from the analyst community.

Retail Sector Takes Center Stage

The most intriguing call of the day came from Barclays analyst Adrienne Yih, who trimmed Dick's Sporting Goods (DKS) price target from $246 to $242 while maintaining an Overweight rating. With shares settling at $207.41 on Tuesday, that $242 target implies roughly 17% upside. Not too shabby for a retailer navigating today's choppy consumer spending environment.

Yih also had thoughts on Abercrombie & Fitch Co (ANF), raising the target from $84 to $94 with an Equal-Weight rating. Abercrombie shares closed at $95.14 on Wednesday, meaning the stock has already sailed past the analyst's target. Sometimes the market moves faster than the forecasts.

Over at UBS, analyst Michael Lasser boosted Five Below Inc (FIVE) from $184 to $204, keeping a Buy rating intact. Five Below shares closed at $166.95 on Wednesday, suggesting Lasser sees meaningful upside in the discount retailer's trajectory.

Macy's Inc (M) got some attention from Telsey Advisory Group, where analyst Dana Telsey increased the price target from $17 to $22 with a Market Perform rating. Macy's shares closed at $22.43 on Wednesday, trading right around that new target level.

Industrial Names Face Pressure

JP Morgan analyst Jeffrey Zekauskas had a rough day for industrial coverage, slashing targets on two companies. Cabot Corp (CBT) saw its target drop from $75 to $54 with an Underweight rating maintained. Cabot shares closed at $63.80 on Wednesday, still above the target but clearly facing headwinds in Zekauskas's view.

The more dramatic cut came for Orion SA (OEC), where Zekauskas chopped the target from $9 to $5 while keeping an Underweight rating. Orion shares closed at $5.15 on Wednesday, essentially trading at the new target level.

International and Tech Moves

Chinese stocks got mixed treatment. Nio Inc - ADR (NIO) received a modest boost from Barclays analyst Jiong Shao, who raised the price target from $3 to $4 while maintaining an Underweight rating. Nio shares closed at $5.46 on Wednesday, trading well above even the revised target despite the negative rating.

Bilibili Inc - ADR (BILI) faced a small cut from B of A Securities analyst Brad Sills, who lowered the target from $32 to $31 but kept a Buy rating. Bilibili shares closed at $26.41 on Wednesday, suggesting Sills still sees upside potential even after the adjustment.

Financial and Pharma Rounding Out the List

Blackstone Secured Lending Fund (BXSL) saw its target reduced by B of A Securities analyst Wamsi Mohan from $33.5 to $29, though the Buy rating remained. Shares settled at $27.49 on Wednesday.

Finally, 60 Degrees Pharmaceuticals Inc (SXTP) got a small trim from Ascendiant Capital analyst Lucas Ward, who cut the target from $3 to $2.8 while maintaining a Buy rating. The stock closed at $1.05 on Wednesday, trading well below the target and suggesting Ward sees substantial upside if the company can execute.

These target adjustments reflect analysts continuously recalibrating their models based on company performance, sector trends, and broader market conditions. Whether these forecasts prove prescient or overly optimistic remains to be seen, but they offer a snapshot of where Wall Street's research desks see opportunities and risks heading into the next phase of earnings season.

Back to News

Wall Street Sees Dick's Sporting Goods Jumping 17% Plus 9 Other Friday Forecast Moves

MarketDash Editorial Team
10 days ago
Analysts made some notable calls on Friday, adjusting price targets across retail, pharma, and industrial sectors. Dick's Sporting Goods caught attention with a target suggesting significant upside, while targets shifted dramatically for companies ranging from discount retailers to Chinese EV makers.

Wall Street analysts shuffled their price targets across a diverse group of stocks Friday, making moves that ranged from modest tweaks to dramatic reassessments. The headline grabber? Dick's Sporting Goods Inc (DKS) maintained its bullish outlook despite a slight trim, while several other retail names caught fresh attention from the analyst community.

Retail Sector Takes Center Stage

The most intriguing call of the day came from Barclays analyst Adrienne Yih, who trimmed Dick's Sporting Goods (DKS) price target from $246 to $242 while maintaining an Overweight rating. With shares settling at $207.41 on Tuesday, that $242 target implies roughly 17% upside. Not too shabby for a retailer navigating today's choppy consumer spending environment.

Yih also had thoughts on Abercrombie & Fitch Co (ANF), raising the target from $84 to $94 with an Equal-Weight rating. Abercrombie shares closed at $95.14 on Wednesday, meaning the stock has already sailed past the analyst's target. Sometimes the market moves faster than the forecasts.

Over at UBS, analyst Michael Lasser boosted Five Below Inc (FIVE) from $184 to $204, keeping a Buy rating intact. Five Below shares closed at $166.95 on Wednesday, suggesting Lasser sees meaningful upside in the discount retailer's trajectory.

Macy's Inc (M) got some attention from Telsey Advisory Group, where analyst Dana Telsey increased the price target from $17 to $22 with a Market Perform rating. Macy's shares closed at $22.43 on Wednesday, trading right around that new target level.

Industrial Names Face Pressure

JP Morgan analyst Jeffrey Zekauskas had a rough day for industrial coverage, slashing targets on two companies. Cabot Corp (CBT) saw its target drop from $75 to $54 with an Underweight rating maintained. Cabot shares closed at $63.80 on Wednesday, still above the target but clearly facing headwinds in Zekauskas's view.

The more dramatic cut came for Orion SA (OEC), where Zekauskas chopped the target from $9 to $5 while keeping an Underweight rating. Orion shares closed at $5.15 on Wednesday, essentially trading at the new target level.

International and Tech Moves

Chinese stocks got mixed treatment. Nio Inc - ADR (NIO) received a modest boost from Barclays analyst Jiong Shao, who raised the price target from $3 to $4 while maintaining an Underweight rating. Nio shares closed at $5.46 on Wednesday, trading well above even the revised target despite the negative rating.

Bilibili Inc - ADR (BILI) faced a small cut from B of A Securities analyst Brad Sills, who lowered the target from $32 to $31 but kept a Buy rating. Bilibili shares closed at $26.41 on Wednesday, suggesting Sills still sees upside potential even after the adjustment.

Financial and Pharma Rounding Out the List

Blackstone Secured Lending Fund (BXSL) saw its target reduced by B of A Securities analyst Wamsi Mohan from $33.5 to $29, though the Buy rating remained. Shares settled at $27.49 on Wednesday.

Finally, 60 Degrees Pharmaceuticals Inc (SXTP) got a small trim from Ascendiant Capital analyst Lucas Ward, who cut the target from $3 to $2.8 while maintaining a Buy rating. The stock closed at $1.05 on Wednesday, trading well below the target and suggesting Ward sees substantial upside if the company can execute.

These target adjustments reflect analysts continuously recalibrating their models based on company performance, sector trends, and broader market conditions. Whether these forecasts prove prescient or overly optimistic remains to be seen, but they offer a snapshot of where Wall Street's research desks see opportunities and risks heading into the next phase of earnings season.